What Is It?
Sanofi is committed to collaborating with partners to advance cutting-edge discoveries. The Sanofi Innovations in Data Exploration and Analytics (iDEA) Awards program, launched in 2018, provides seed funding to innovators at research centers and early start-ups across North America to transform breakthrough digital, data science tools and new technologies into solutions that accelerate the R&D pipeline and improve people’s lives. In 2022, the iDEA awards (NA) and iTECH awards (Europe) merged into the Sanofi global iDEA-TECH awards.
Sanofi iDEA-TECH Awards 2023
Recent award recipients share how winning this award and collaborating with Sanofi researchers has impacted their work.
About the Program
- Seed funding of $150.000 USD
- 1 year project duration
- Dedicated Sanofi Project Champion and resources (subject matter experts)
- A stepping stone to further collaboration
The Call for Projects is Open!
Sanofi’s iDEA-TECH Program request for Pre-proposals is open until December 12th, 2024. Please review the submission instructions and scope of the call and use the provided template when completing your application (documents available below).
Examples of Partnering Opportunities
Predict patient outcomes
Predict & track disease progression & drug effects
Maximize drug value in the real world
Optimize clinical trial design
Drug target enabling platforms
Biomarker Identification
Test new digital/AI solutions
High throughput screening approaches
Analytic tools to understand drug mechanism or product quality
Testimonials
“The iDEA-TECH Awards initiative is providing a unique opportunity to work as a team to study itch in kids with atopic dermatitis in the comfort of their homes by incorporating our Emerald AI technology. It has been exciting to work so closely with the Sanofi team around a shared commitment to breaking new grounds for this important population.”
Dina Katabi, PhD, Thuan and Nicole Pham Professor, MIT President and co-Founder, Emerald Innovations, Inc.
iDEA-TECH Recipients for the 2023-2024 Cycle
Marinka Zitnik, PhD
Harvard University
Fei Wang, PhD
Weill Cornell Medicine
Nam Chu, PhD
The Ohio State University
Joshua Leonard, PhD
Northwestern University
Jason Meyer, PhD
Trustees of Indiana University
Ruijiang Li, PhD
Stanford
Jianmin Gao, PhD
Boston College
Anna Jagielska, PhD
Artificial Axon Labs Inc.
Tali Konry, PhD
Northeastern University
Olivier Elemento, PhD
Weill Cornell Medicine
Possu Huang, PhD
Stanford
Phillip Kim, PhD
Fable Therapeutics
Joint Publications
Disease progression strikingly differs in research and real-world Parkinson's populations
Harvard Medical School, Brett Beaulieu-Jones and Isaac Kohane, 2024